IMCY-0141

· Imcyse SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMCY-0141, covering 2024-03-08 to 2024-03-08. Get the full timeline:

Most recent: Clinical Trial Update: IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study [Phase 1, Phase 2]